Compounded Dermatology Medications: What Prescribers Need to Know

Dermatology has one of the strongest clinical cases for compounding. Patients present with conditions that demand specific concentrations, unique ingredient combinations, or vehicles that commercial products simply don’t offer. A patient who needs a higher-strength tretinoin than what’s commercially available. A combination antifungal-steroid-antibiotic in a single topical. A hydroquinone preparation without a specific preservative that triggers contact dermatitis. These are everyday clinical scenarios in dermatology—and compounding addresses them.

Yet many prescribers default to commercial alternatives or avoid compounding entirely because the ordering workflow is cumbersome, quality is uncertain, or they’re unsure what’s available. This guide covers the clinical landscape of compounded dermatology medications—common formulations, quality considerations, and how digital prescribing tools are making dermatology compounding more accessible.

When Compounded Dermatology Formulations Are Clinically Indicated

FDA-approved dermatology products cover a wide therapeutic range, and they should be the starting point when they meet the patient’s needs. Compounding becomes relevant in specific clinical circumstances:

Custom concentration requirements. A patient may need a strength that isn’t commercially available—a higher or lower concentration of a retinoid, a non-standard percentage of hydroquinone, or a steroid potency between two available commercial products. Compounding allows precise strength adjustments.

Multi-agent combination therapy. Dermatology frequently benefits from combining multiple active ingredients into a single preparation. A melasma formulation combining hydroquinone, tretinoin, and a corticosteroid. A wound care compound with an antimicrobial, analgesic, and healing agent. Commercial products rarely offer these combinations, and applying three separate products creates compliance challenges for patients.

Allergen or excipient avoidance. Patients with contact sensitivities to preservatives, fragrances, dyes, or specific vehicle ingredients may react to a commercial product’s inactive ingredients. Compounding allows the active drug to be delivered in a hypoallergenic base free of the offending excipient.

Vehicle optimization. The vehicle matters in dermatology. An ointment base for severely dry plaques, a gel for seborrheic areas, a foam for scalp application, a cream for cosmetically sensitive areas. Compounding lets the prescriber match the vehicle to the body site and skin condition rather than accepting whatever vehicle the manufacturer chose.

Common Compounded Dermatology Formulations

The following formulations represent the most frequently compounded dermatology preparations. Concentrations reflect common prescribing ranges; individual clinical judgment should always guide specific prescribing decisions.

Hyperpigmentation and Melasma. The modified Kligman’s triple combination cream remains one of the most widely prescribed compounded dermatology formulations. A typical preparation combines hydroquinone (4–8%), tretinoin (0.025–0.05%), and fluocinolone acetonide (0.01%) in a single topical cream. Compounding allows prescribers to adjust the hydroquinone concentration beyond the 4% ceiling of most commercial products and to customize the vehicle for patient tolerance.

Acne. Custom retinoid and antibiotic combinations give prescribers flexibility that commercial fixed-dose products cannot match. Common formulations include tretinoin (0.025–0.1%) paired with clindamycin (1%) and niacinamide (4–5%). Compounding allows the prescriber to fine-tune retinoid strength based on patient tolerance and to add agents like niacinamide for barrier support—combinations not available in any single commercial product.

Anti-Aging and Photoaging. High-strength retinoid and antioxidant creams are among the most requested compounded preparations in cosmetic dermatology. Formulations typically feature tretinoin (0.05–0.1%) combined with vitamin C (10–20%) and hyaluronic acid in a cosmetically elegant base. Compounding allows concentrations of vitamin C and retinoid that exceed what’s available in over-the-counter or prescription commercial products.

Fungal Infections. Multi-agent antifungal topicals combine two or more antifungal agents—such as ketoconazole (2%) and clotrimazole (1%)—sometimes with a low-potency corticosteroid to manage inflammation. This approach is particularly useful for refractory dermatophyte infections or mixed fungal-inflammatory presentations where a single commercial antifungal has proven insufficient.

Psoriasis and Eczema. Steroid and keratolytic combinations address both inflammation and hyperkeratosis in a single application. Common formulations pair betamethasone (0.05–0.1%) with salicylic acid (3–6%) and calcipotriene (0.005%). Compounding allows the prescriber to adjust steroid potency by body site—lower for face and flexures, higher for thick plaques on elbows and knees—in a way that fixed commercial products cannot accommodate.

Wound Care. Antimicrobial and healing agent preparations combine ingredients like mupirocin (2%) with agents that promote tissue repair—misoprostol, phenytoin, or nifedipine—tailored to the wound type and healing stage. These multi-agent compounds are used in chronic wound management, post-surgical care, and pressure injury treatment where commercial wound care products offer insufficient therapeutic breadth.

Scar Management. Silicone-based preparations with active ingredients offer a compounded alternative to commercial scar sheets and gels. Formulations may combine a silicone base with vitamin E, onion extract, and a low-potency corticosteroid. Compounding allows the prescriber to adjust the active ingredient profile based on scar type (hypertrophic, keloid, post-surgical) and patient response.

Alopecia. Scalp-targeted formulations represent a growing area of compounding interest. Common preparations include minoxidil at higher concentrations than commercially available (5–12.5%), often combined with topical finasteride (0.1–0.25%) and latanoprost (0.005%) in a single scalp solution. Compounding is the only way to deliver these multi-agent combinations in a single application.

Nail Conditions. Nail-penetrating antifungal formulations use specialized vehicles—often DMSO-based—to deliver antifungal agents like ciclopirox and terbinafine through the nail plate. Onychomycosis is notoriously difficult to treat topically with commercial products; compounded formulations with enhanced penetration vehicles offer an alternative for patients who cannot tolerate or prefer to avoid systemic antifungals.

Note: Compounded preparations are not FDA-approved. Prescribers should document the clinical rationale for compounding, explain to patients that the formulation is custom-prepared, and select accredited compounding pharmacies to minimize quality variability.

Quality Matters More in Dermatology Than You Think

Topical compounding quality directly affects therapeutic outcomes. Potency accuracy determines whether the active ingredient is delivered at the intended concentration. Vehicle stability determines whether the active remains evenly distributed and bioavailable throughout the preparation’s shelf life. Beyond-use dating (BUD) determines how long the compound remains clinically effective.

Studies have documented significant potency variability in compounded preparations across pharmacies. For topical dermatology compounds—where a 4% hydroquinone cream that tests at 2.8% delivers a meaningfully different clinical effect—this variability has real patient-care implications.

PCAB-accredited pharmacies are held to rigorous standards for compounding consistency, potency verification, and ingredient sourcing from FDA-registered suppliers. For dermatology prescribers who send compound orders regularly, routing those orders exclusively to accredited pharmacies is the simplest way to control for quality variability.

How to Order Compounded Dermatology Medications Digitally

Historically, prescribing a compounded dermatological preparation meant calling a specific pharmacy, discussing the formulation details, and faxing a written order. Digital prescribing platforms designed for compounding eliminate this friction.

eNavvi’s platform provides access to pre-formulated dermatology templates for the most commonly prescribed compounds—including melasma combinations, high-strength retinoids, and custom alopecia formulations. Each template is fully customizable: adjust concentrations, change the vehicle base, add or remove ingredients, and modify quantities within the digital workflow. Real-time cash pricing from multiple PCAB-accredited pharmacies is displayed side by side, so prescribers can compare costs before finalizing the order.

For dermatology practices that prescribe compounds regularly, this workflow replaces dozens of phone calls and faxes per week with a single digital interface—complete with audit trails, HIPAA-secure transmission, and documented formulation records for each patient.

Browse Dermatology Compound Templates

Explore eNavvi’s pre-formulated dermatology compounds—melasma, acne, alopecia, wound care, and more—with transparent cash pricing across PCAB-accredited pharmacies.

Get Started Free at eNavvi.com →

Frequently Asked Questions

Q: What dermatology medications can be compounded?

A: Nearly any topical dermatology medication can be compounded, including retinoids (tretinoin), hydroquinone, antifungals (ketoconazole, terbinafine), corticosteroids, antibiotics (clindamycin, mupirocin), minoxidil for alopecia, and multi-agent combinations. Compounding allows custom concentrations, allergen-free bases, and combination formulations that are not commercially available.

Q: Are compounded dermatology medications covered by insurance?

A: Most compounded dermatology medications are cash-pay and are not covered by insurance. Because they are custom-prepared without FDA approval, insurance plans and PBMs typically do not adjudicate claims for compounded topicals. This makes transparent cash pricing especially important—platforms like eNavvi display real-time prices from multiple pharmacies so prescribers and patients can compare costs before the order is placed.

Q: How do I choose a compounding pharmacy for dermatology prescriptions?

A: Look for PCAB accreditation (only ~8% of U.S. pharmacies hold this), verify they compound dermatology formulations regularly (volume indicates process consistency), confirm ingredient sourcing from FDA-registered suppliers, and ask about potency testing protocols. Digital prescribing platforms like eNavvi include only accredited pharmacies in their network, simplifying the selection process.